U.S. Litigation Caused by Novel Coronavirus, and Strategies for Japanese Businesses
January 21, 2021
Partners Etsuo Doi and Adrian Jensen wrote an article titled, “U.S. Litigation Caused by Novel Coronavirus, and Strategies for Japanese Businesses,” for the Japanese-language publication Business Law magazine.
Please click here to view the article.
Author(s)
Related Insights
February 25, 2026
Tariff & International Trade Resource
What Every Multinational Should Know About…Managing the Aftermath of the Supreme Court’s IEEPA Tariff Decision (Part III)
Importers of record need to take steps to ensure that they are best positioned to secure any refunds, while also ensuring that they are adapting to the new replacement tariffs. So, on the customs side, we recommend these steps for importers of record to handle these customs issues.
February 24, 2026
Foley Viewpoints
Bridging AI and Clinical Reality: Lessons from the Mayo Clinic Platform in Precision Medicine
Artificial intelligence is no longer a peripheral tool in personalized medicine. AI is becoming a central driver of how diagnostics,…
February 24, 2026
Tariff & International Trade Resource
What Every Multinational Should Know About …The New Section 122 Tariffs and Preserving IEEPA Refund Rights
In the immediate aftermath of the U.S. Supreme Court’s decision invalidating tariffs imposed under the International Emergency Economic Powers Act (IEEPA), the Trump administration has moved quickly to replace those tariffs with a new across-the-board tariff under Section 122 of the Trade Act of 1974.